Eribulin mesylate
Eribulin Mesylate is a generic prescription drug used intravenously to treat certain cancers. It's a microtubule inhibitor that comes as a solution in single-dose vials (0.5 mg/mL strength). Manufactured by Hikma Pharmaceuticals USA Inc., it's approved under ANDA 218281. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Eribulin Mesylate is a generic prescription drug used intravenously to treat certain cancers. It's a microtubule inhibitor that comes as a solution in single-dose vials (0.5 mg/mL strength). Manufactured by Hikma Pharmaceuticals USA Inc., it's approved under ANDA 218281. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Eribulin mesylate", "mediaType": "text/html", "description": " Access the FDA dataset for Eribulin mesylate — ANDA 201532 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201532" } ] |
| identifier | ANDA201532 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "fda", "health-care", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Eribulin mesylate |
